Kezar Life Sciences (KZR) Net Margin (2021 - 2025)
Historic Net Margin for Kezar Life Sciences (KZR) over the last 5 years, with Q2 2025 value amounting to 4537.75%.
- Kezar Life Sciences' Net Margin fell 8355700.0% to 4537.75% in Q2 2025 from the same period last year, while for Sep 2025 it was 7777.81%, marking a year-over-year decrease of 41794900.0%. This contributed to the annual value of 1455.29% for FY2023, which is N/A changed from last year.
- Per Kezar Life Sciences' latest filing, its Net Margin stood at 4537.75% for Q2 2025, which was down 8355700.0% from 4771.18% recorded in Q1 2025.
- In the past 5 years, Kezar Life Sciences' Net Margin registered a high of 8938.36% during Q4 2021, and its lowest value of 330.04% during Q3 2023.
- Its 5-year average for Net Margin is 5327.83%, with a median of 5682.8% in 2022.
- In the last 5 years, Kezar Life Sciences' Net Margin skyrocketed by 3626600bps in 2023 and then tumbled by -9404500bps in 2024.
- Over the past 5 years, Kezar Life Sciences' Net Margin (Quarter) stood at 8938.36% in 2021, then tumbled by -33bps to 5951.1% in 2022, then tumbled by -106bps to 330.04% in 2023, then surged by 1728bps to 5373.32% in 2024, then fell by -16bps to 4537.75% in 2025.
- Its last three reported values are 4537.75% in Q2 2025, 4771.18% for Q1 2025, and 5373.32% during Q2 2024.